Paper
0
Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
Authors
Ellen Goode,Matthew Block
Kimberly Kalli,Robert Vierkant,Wenqian Chen,Zachary Fogarty,Aleksandra Gentry‐Maharaj,Aleksandra Tołoczko,Alexander Hein,Aliecia Bouligny,Allan Jensen,Ana Osório,Andreas Hartkopf,Andy Ryan,Anita Chudecka-Głaz,Anthony Magliocco,Arndt Hartmann,Audrey Jung,Bo Gao,Brenda Hernandez,Brooke Fridley,Bryan McCauley,Catherine Kennedy,Chen Wang,Chloe Karpinskyj,Christiani Sousa,Daniel Tiezzi,David Wachter,Esther Herpel,FA Taran,Francesmary Modugno,Gregg Nelson,Jan Lubiński,Janusz Menkiszak,Jennifer Alsop,Jenny Lester,Jesús García-Donás,Jill Nation,Jillian Hung,José Palacios,Leigha Senter,Joseph Kelley,Jurandyr Andrade,Luis Díaz‐Robles,Maria Intermaggio,Martin Widschwendter,Matthias Beckmann,Matthias Ruebner,Mercedes Jimenez‐Liñan,Naveena Singh,Oleg Oszurek,Paul Harnett,Peter Rambau,Hans‐Peter Sinn,Philipp Wagner,Prafull Ghatage,Raghwa Sharma,Robert Edwards,Roberta Ness,Sandra Oršulić,Sara Brucker,Penelope Webb,Teri Longacre,Ursula Eilber,Valerie McGuire,Weiva Sieh,Yanina Natanzon,Zheng Li,Alice Whittemore,Anna deFazio,Annette Staebler,Beth Karlan,C. Gilks,David Bowtell,Estrid Høgdall,Francisco Reis,Helen Steed,Ian Campbell,Jacek Gronwald,Javier Benı́tez,Jennifer Koziak,Claude Houdayer,Kirsten Moysich,Linda Kelemen,Linda Cook,Marc Goodman,María García,Peter Fasching,Stefan Kommoss,Suha Deen,Susanne Kjær,Usha Menon,James Brenton,Paul Pharoah,Georgia Chenevix‐Trench,David Huntsman,Stacey Winham,Martin Köbel,Susan Ramus,Joseph Rothstein,Matthias Rübner,Jenny Chang‐Claude,Sharon Johnatty
+101 authors
,Ana OsorioJournal
Published
Oct 19, 2017
Show more
Save
Tip0
TipSave
Abstract
Cytotoxic CD8+ tumor-infiltrating lymphocytes (TILs) participate in immune control of epithelial ovarian cancer; however, little is known about prognostic patterns of CD8+ TILs by histotype and in relation to other clinical factors.
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.